Replies to post #20679 on Avid Bioservices Inc (CDMO)

[keep_trying]

Jazz, Bavi is showing potential for being part of standard of care treatment for just about all the major viral infections that afflict people around the planet. It seems like disruption of PS such that Bavi can glom onto the inverted PS is involved with so many maladies that a listing could easily fill a page.

So, how long will it be before PPHM and Bavi's role gets recognized by the investment community? It sounds like timing for Duke and other related research being released could happen any time and that the March conference schedule is a likely high profile arena for Bavi recognition.

Thanks for sharing your research about how the many avenues in which the mechanism that Bavi is effective in are related to treatment of diseases of concern to us all.

Best wishes and IMO.
KT

[jazzbeerman]

OT: Gates Foundation vs: Malaria -



July 2006:


Johns Hopkins Launches Effort to Spur Global Action on Malaria

The Johns Hopkins Bloomberg School of Public Health Center for Communication Programs has announced a new advocacy initiative designed to highlight successful anti-malaria efforts and evidence-based results that can contribute to a malaria-free future for families in the developing world.

In making the announcement, Baltimore-based CCP's Global Program on Malaria said it launched the initiative, VOICES for a Malaria-Free Future, to educate policy makers about effective programs and strategies for malaria control. Supported by an $8.7 million grant from the Bill & Melinda Gates Foundation, VOICES will work with the Global Fund to Fight AIDS, Tuberculosis and Malaria


http://foundationcenter.org/pnd/news/story.jhtml?id=152700006



---------------------



Dec 2006:

Gates Foundation Commits $83.5 Million to Fight Against Malaria

The Seattle-based Bill & Melinda Gates Foundation has announced an $83.5 million commitment to combat malaria, which kills more than two thousand African children a day and claims the lives of more than a million people worldwide every year.

The funds will be used to accelerate research on vaccines and other prevention methods, expand access to bednets, treatment, and anti-malaria tools, and boost global advocacy efforts to fight the disease.

http://foundationcenter.org/pnd/news/story.jhtml?id=164400017



------------------------





Oct 2005:

Gates Foundation pledges 250 Million, over 5 years, towards fighting malaria.

http://www.washingtonpost.com/wp-dyn/content/article/2005/10/30/AR2005103000700.html



---------


j

[sunstar]

Jazz, PS is looking, more and more, like a universal marker of disease in humans.

First it was cancer: PS, as we now know, is exposed on dead, dying and cancer stressed cells.

What a surprise to find that the same PS phenomenon was occurring also as a result of infection by all these serious disease causing enveloped viruses: HIV, Flu, Hep C, deadly Ebola and the many others in this group.

Bavituximab has already been shown to successfully target PS on many different tumor types and all the enveloped viruses tested to date.

These diseases, alone, constitute a massive portion of human medicine: many, maybe most, of the cancers that kill us. It’s very likely that bavi targets all the enveloped viruses too, because they all expose PS.

Think very carefully about how big of a market we’re talking about.

It’s starting to look like we will be finding even more diseases that expose PS. Many of these outside papers that Jazz has been showing the board are mentioning these: Malaria, Leishmania. (That’s when your dog turns on you during a walk in the park)

It makes total sense, when you think about it, that when disease agents start attacking your cells: killing them, that they would be dying and exposing PS.

This is why bavituximab is going to be SO BIG.

sunstar